Squarepoint Ops LLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 66 filers reported holding RECRO PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q2 2023$98,398
+105.0%
89,453
+238.6%
0.00%
Q1 2022$48,000
-50.0%
26,417
-52.7%
0.00%
Q4 2021$96,000
-53.4%
55,848
-44.1%
0.00%
-100.0%
Q3 2021$206,000
-12.0%
99,849
-1.6%
0.00%0.0%
Q2 2021$234,000
+470.7%
101,453
+599.5%
0.00%
Q4 2020$41,000
-71.9%
14,504
-54.8%
0.00%
-100.0%
Q2 2020$146,000
-45.1%
32,083
-1.3%
0.00%
-71.4%
Q1 2020$266,000
-84.6%
32,506
-65.6%
0.01%
-30.0%
Q4 2019$1,730,000
-8.0%
94,408
-44.4%
0.01%
-41.2%
Q3 2019$1,880,000
-7.5%
169,683
-15.1%
0.02%
-15.0%
Q2 2019$2,032,000
+229.3%
199,820
+89.7%
0.02%
+185.7%
Q1 2019$617,000
+6.2%
105,346
+28.8%
0.01%0.0%
Q4 2018$581,000
+88.6%
81,794
+88.9%
0.01%
+75.0%
Q3 2018$308,000
-35.0%
43,300
-54.2%
0.00%
-33.3%
Q2 2018$474,000
+21.2%
94,491
+165.7%
0.01%0.0%
Q1 2018$391,000
+181.3%
35,557
+123.9%
0.01%
+50.0%
Q1 2017$139,000
-47.3%
15,881
-51.6%
0.00%
-63.6%
Q4 2016$264,00032,8000.01%
Other shareholders
RECRO PHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Engine Capital Management, LP 872,494$6,195,0003.64%
Newtyn Management, LLC 1,600,000$11,360,0002.22%
Broadfin Capital, LLC 2,048,025$14,541,0001.91%
Balter Liquid Alternatives, LLC 92,167$654,0000.45%
ESSEX INVESTMENT MANAGEMENT CO LLC 515,414$3,660,0000.29%
JT Stratford LLC 45,367$322,0000.21%
Opus Point Partners Management, LLC 11,353$81,0000.18%
Alyeska Investment Group, L.P. 964,000$6,844,0000.10%
KENNEDY CAPITAL MANAGEMENT LLC 500,625$3,554,0000.09%
Monarch Partners Asset Management LLC 55,857$397,0000.06%
View complete list of RECRO PHARMA INC shareholders